Literature DB >> 2188836

Sympathetic activation in congestive heart failure.

G Mancia1.   

Abstract

This paper reviews the evidence that congestive heart failure is characterized by an increase in sympathetic nerve activity and that this may begin in an early symptomatic phase and progress with the severity of the disease. The sympathetic activation initially plays a compensatory role but eventually is outweighted by adverse consequences at both cardiac and vascular levels which may aggravate the clinical status and negatively affect prognosis. This is likely to depend on the fact that the sympathetic activation becomes excessive due to reduction in sensitivity of baroreflexes and cardiopulmonary reflexes restraining sympathetic tone (functional reflex denervation) and positive interactions between the sympathetic and the renin-angiotensin system. Therapeutic interventions may reduce the marked sympathetic activation which occurs in heart failure, and in some instances (particularly with digitalis compounds) may also improve the impaired sensitivity of reflex cardiovascular control.

Entities:  

Mesh:

Year:  1990        PMID: 2188836     DOI: 10.1093/eurheartj/11.suppl_a.3

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  18 in total

1.  Reduction in synaptic GABA release contributes to target-selective elevation of PVN neuronal activity in rats with myocardial infarction.

Authors:  Tae Hee Han; Kiho Lee; Jin Bong Park; Dongchoon Ahn; Jae-Hyeong Park; Dae-Yong Kim; Javier E Stern; So Yeong Lee; Pan Dong Ryu
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-02-17       Impact factor: 3.619

Review 2.  Role of paraventricular nucleus in mediating sympathetic outflow in heart failure.

Authors:  K P Patel
Journal:  Heart Fail Rev       Date:  2000-03       Impact factor: 4.214

3.  Enhanced NMDA receptor-mediated intracellular calcium signaling in magnocellular neurosecretory neurons in heart failure rats.

Authors:  Javier E Stern; Evgeniy S Potapenko
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-06-19       Impact factor: 3.619

Review 4.  Coupling between respiratory and sympathetic activities as a novel mechanism underpinning neurogenic hypertension.

Authors:  Daniel B Zoccal; Benedito H Machado
Journal:  Curr Hypertens Rep       Date:  2011-06       Impact factor: 5.369

5.  Hemodynamic correlates of baroreflex impairment of heart rate in experimental canine heart failure.

Authors:  M Brändle; W Wang; I H Zucker
Journal:  Basic Res Cardiol       Date:  1996 Mar-Apr       Impact factor: 17.165

6.  Angiotensin-converting enzyme 2 overexpression improves central nitric oxide-mediated sympathetic outflow in chronic heart failure.

Authors:  Hong Zheng; Xuefei Liu; Kaushik P Patel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-30       Impact factor: 4.733

7.  Beta blockers in heart failure: a comparison of a vasodilating beta blocker with metoprolol.

Authors:  J E Sanderson; S K Chan; C M Yu; L Y Yeung; W M Chan; K Raymond; K W Chan; K S Woo
Journal:  Heart       Date:  1998-01       Impact factor: 5.994

Review 8.  Combination diuretic therapy in severe congestive heart failure.

Authors:  T P Dormans; P G Gerlag; F G Russel; P Smits
Journal:  Drugs       Date:  1998-02       Impact factor: 9.546

9.  Sympathoexcitation in response to cardiac and pulmonary afferent stimulation of TRPA1 channels is attenuated in rats with chronic heart failure.

Authors:  Ryan J Adam; Zhiqiu Xia; Kristina Pravoverov; Juan Hong; Adam J Case; Harold D Schultz; Steven J Lisco; Irving H Zucker; Han-Jun Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

Review 10.  Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure.

Authors:  Irving H Zucker; Harold D Schultz; Kaushik P Patel; Wei Wang; Lie Gao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.